Vivian Lanius

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Ludwig Kappos, Mark S. Freedman, Chris H. Polman et al. · The Lancet · 2007 · 501 citations

Life Sciences, Neurology, Neuroimmunology +9

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease

Sonia S. Anand, François Caron, John W. Eikelboom et al. · Journal of the American College of Cardiology · 2018 · 457 citations

Medicine, Orthopedic Surgery, Surgery +13

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein et al. · European Heart Journal · 2014 · 370 citations

Medicine, Cardiology, Pharmacotherapy +17

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Ludwig Kappos, Mark S. Freedman, Chris H. Polman et al. · The Lancet Neurology · 2009 · 370 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +11

Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

Britta Maurer, Nicole Graf, Beat A. Michel et al. · Annals of the Rheumatic Diseases · 2014 · 126 citations · Full text

Medicine, Clinical Sciences, Dermatology +16